<< Back to Results
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When AMG 145 is Used in Combination With Statin Therapy in Patients with Clinically Evident Cardiovascular Disease. FOURIER: Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk.
Clinical Trial Categories
- Annette Fudala, RMA, CRC at 215-355-9770
- Feasterville Family Health Care Center N/A
1665 Bustleton Pike
Feasterville, PA 19053